|
|
- 2017
抗肿瘤药物临床试验的特点和医学伦理问题DOI: 10.3971/j.issn.1000-8578.2017.16.1559 Keywords: A Systemic Analysis,Application of Cell-penetrating Peptides in Tumor Target Therapy,Review on Low-molecular-weight Heparin in Improving Prognosis of Pancreatic Cancer,PhaseⅠClinical Trial of Cisplatin Metronomic Chemotherapy Combined with#br# Radiotherapy in Locoregionally Mid-late Stage Nasopharyngeal Carcinoma,Effects of 9-cis-Retinoic Acid on the Expression of CD44 and CD54 in Lung Cancer Cell Lines Abstract: 摘要 抗肿瘤药物的研发离不开高质量的临床试验，与非抗肿瘤药物相比，其临床试验既有共性也有特殊性，其相关医学伦理问题也日益引起人们的重视。探讨并总结抗肿瘤药物临床试验的研究对象、受试者招募、知情同意、试验设计、疗效观察和安全性评价等主要内容的特点及相关医学伦理问题，为抗肿瘤药物临床试验更好地保护受试者，以及更加规范化地实施和长远发展提供科学依据和参考
|
